NEW YORK, Dec. 13 – Aventis has subscribed to a selection of samples in Gene Logic’s database, Gene Logic said Thursday.

Under the terms of the deal, Aventis will have access to samples culled from Gene Logic’s BioExpress database. The BioExpress database contains gene expression information for normal and diseased human tissues, tissues from model animal systems, and human and animal cell lines for use in drug target identification.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.